When was Alligator Bioscience founded?

Alligator Bioscience was founded in 2001 and raised its 1st funding round 14 years after it was founded.

Where is Alligator Bioscience located?

Alligator Bioscience is headquartered in Lund, Sweden.

How many employees does Alligator Bioscience have?

As of Sep 30, 2026, the latest employee count at Alligator Bioscience is 26.

Is Alligator Bioscience a funded company?

Alligator Bioscience is a funded company, having raised a total of $10M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 01, 2015.

When was the latest funding round of Alligator Bioscience?

Alligator Bioscience's latest funding was a $***** Grant (prize money) round on Oct 05, 2018, with participation from 1 investor.

Where does Alligator Bioscience rank among its competitors?

Alligator Bioscience ranks 307th amongst 3355 active competitors, of which 1131 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Alligator Bioscience?

Alligator Bioscience's top competitors include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Alligator Bioscience - 2026 Company Profile, Funding & Competitors

Company Details

Developer of antibody-based immunotherapies for the treatment of cancer. The proprietary technology platforms include the human antibody library ALLIGATOR-GOLD and the protein optimization technology FIND. The pipeline consists of ADC-1013 a CD40 agonistic human monoclonal antibody, ADC-1015 is a bispecific antibody directed towards OX40 and CTLA-4 and ADC-1016 is a bispecific immuno-oncology.

Website: alligatorbioscience.se/en/
Social

Key Metrics

Founded Year

2001

Location

Lund, Sweden

Stage

Public

Total Funding

$10M in 2 rounds

Latest Funding Round

Grant (prize money), Oct 05, 2018, $*****

Investors

Sunstone & 9 more

Ranked

307^th among 3355 active competitors

Employee Count

26 as on Sep 30, 2026

Similar Companies

Jazz Pharmaceuticals & 3057 more

Exit Details

Public

View Alligator Bioscience's full profile

Alligator Bioscience got listed on Nov 23, 2016.

Click here to take a look at Alligator Bioscience's IPO in detail

Alligator Bioscience has raised a total funding of $10M over 2 rounds. Its first funding round was on Oct 01, 2015. Its latest funding round was a Grant (prize money) round on Oct 05, 2018 for $*****. 1 investor participated in its latest round. Alligator Bioscience has 10 institutional investors.

Here is the list of recent funding rounds of Alligator Bioscience:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 05, 2018	7191673	Grant (prize money)	3757392	1052421	9903218	1518553
Oct 01, 2015	9002640	Series A	3884945	9211313	2432663	6740201

Access funding benchmarks and valuations. Sign up today!

View details of Alligator Bioscience's funding rounds and investors

Alligator Bioscience's employee count trend

Alligator Bioscience has 26 employees as of Sep 26. Here is Alligator Bioscience's employee count trend over the years:

Employee count trend for Alligator Bioscience

Uncover Alligator Bioscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alligator Bioscience include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Alligator Bioscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, T. Rowe Price & 13 others	81/100
3rd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
5th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, Leaps by Bayer & 30 others	72/100
6th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	72/100
9th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	72/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
307th	Alligator Bioscience 2001, Lund (Sweden), Public	Developer of antibody-based immunotherapies for the treatment of cancer	$10M	Sunstone, Allegro Investment Fund & 8 others	57/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Alligator Bioscience's competitors? Click here to see the top ones

Alligator Bioscience has made no investments or acquisitions yet.

Here is the latest report on Alligator Bioscience's sector:

Free

Oncology - Sector Report

Edition: August, 2026 (74 Pages)

View all reports related to Alligator Bioscience

Media has covered Alligator Bioscience for a total of 10 events in the last 1 year, 4 of them have been about company updates and 1 about people movement.